Merck's Idenix Denied Enhanced Damages On $2.5B Verdict
A Delaware federal judge denied enhanced damages Friday to Merck & Co. unit Idenix after its $2.5 billion win over Gilead Sciences Inc. in a jury trial claiming infringement of a...To view the full article, register now.
Already a subscriber? Click here to view full article